N-linked glycosylation of the extracellular domain of PD-L1 could promote the stability by inhibiting 26S proteosome-dependent degradation, while O-linked β-N-acetylglucosamine modification promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation (16). The gene discussed is CD274; the disease is neoplasm.